Showing results (4231-4240 of 27,715) with videos related to
Sort By:
Pageof 2,772
Vaccine|November 22, 2011
Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control studyJesús Castilla, Víctor Martínez-Artola, Esther Salcedo, et al.Vaccine|November 29, 2011
Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccineJennie S Lavine, Ottar N Bjørnstad, Birgitte Freiesleben de Blasio, et al.Vaccine|November 29, 2011
Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009Anne von Gottberg, Cheryl Cohen, Andrew Whitelaw, et al.Vaccine|November 29, 2011
Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing processHitt J Sharma, Vishwanath D Patil, Sanjay K Lalwani, et al.Vaccine|November 29, 2011
Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protectionAmi Patel, Michael Gray, Yan Li, et al.Vaccine|November 29, 2011
Model for competition from self during passive immunization, with application to broadly neutralizing antibodies for HIVS M Ali Tabei, Ying Li, Martin Weigert, et al.Vaccine|November 29, 2011
Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS Blood and Transplant: 2004-2009. Is rubella susceptibility increasing?Lisa Byrne, Lisa Brant, Claire Reynolds, et al.Vaccine|December 3, 2011
Antibody response to allelic variants of 19kDa fragment of MSP-1: recognition of a variant and protection associated with ethnicity in Assam, IndiaSonia D Lourembam, Shashi BaruahVaccine|December 3, 2011
Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeysDavid R Kaufman, Fusheng Li, Ashley N Cruz, et al.Vaccine|November 24, 2011
A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix(®) in subjects aged 11-17 years: an open, randomised, controlled trialLars Østergaard, Sven-Arne Silfverdal, Johan Berglund, et al.Pageof 2,772